Page last updated: 2024-09-03

bradykinin, leu(8)-des-arg(9)- and dibutyldichlorotin

bradykinin, leu(8)-des-arg(9)- has been researched along with dibutyldichlorotin in 1 studies

Compound Research Comparison

Studies
(bradykinin, leu(8)-des-arg(9)-)
Trials
(bradykinin, leu(8)-des-arg(9)-)
Recent Studies (post-2010)
(bradykinin, leu(8)-des-arg(9)-)
Studies
(dibutyldichlorotin)
Trials
(dibutyldichlorotin)
Recent Studies (post-2010) (dibutyldichlorotin)
10207149019

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Q; Lai, J; Ossipov, MH; Porreca, F; Vardanyan, M; Vera-Portocarrero, LP1

Other Studies

1 other study(ies) available for bradykinin, leu(8)-des-arg(9)- and dibutyldichlorotin

ArticleYear
Attenuation of persistent experimental pancreatitis pain by a bradykinin b2 receptor antagonist.
    Pancreas, 2010, Volume: 39, Issue:8

    Topics: Abdominal Pain; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Dynorphins; Ganglia, Spinal; Gene Expression; Immune Sera; Injections, Intraperitoneal; Injections, Intravenous; Injections, Spinal; Male; Organotin Compounds; Pain; Pancreas; Pancreatitis; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Reverse Transcriptase Polymerase Chain Reaction; Spinal Cord

2010